What is the BlueInvest Project Pipeline?
See our showcase of innovative projects and entrepreneurs who are shaping the Blue Economy.
Projects consist of innovative, scalable and sustainable business ventures from traditional and emerging sectors of the maritime economy.
The graphs below provide an overview of the country distribution, sector, and TRL of projects currently listed in the BlueInvest Project Pipeline.
Selection Criteria:
Your company is EU-based or from an eligible sea basin region (Georgia, Turkey, Ukraine, Moldova, Montenegro, Albania, Bosnia-Herzegovina, North Macedonia, Serbia, Turkey, Israel, Egypt, Tunisia, Algeria, Morocco, Lebanon, Syria, Libya, Mauritania, United Kingdom, or Norway)
Your project TRL is 4 or higher
Your project sector is in one of the 10 blue economy sectors identified for this initiative
Your solution has a clear sustainable impact on the blue economy
Your project is looking for investment
Project Country
Country in which the project is being developed and / or implemented.
Project Sector
Main blue economy sector the project relates to.
Project TRL
Current technology readiness level of the project.
Aquatic Biologicals
CEO: Dr. Pantelis Katharios. Senior researcher at the Institute of Marine Biology, Biotechnology and Aquaculture of the Hellenic Centre for Marine Research. He has more than 15 years of experience in the field of Fish Disease Diagnosis and management in aquaculture. He is the author of more than 55 scientific publications and has extensive experience in project management at both national and European level. Dr. Panos Kalatzis. Post-doc researcher at the University of Copenhagen. Expertise in microbiology and phage therapy. Mrs. Constantina Kokkari. Technical Director. She is a biologist with more than 20 years of experience in microbiology. Ms. Maria Smyrli, Biologist with MSc (PhD candidate). Her expertise is on vaccine development for aquaculture fish. Ms. Maria Ioanna Tsertou, Biologist with MSc (PhD candidate). Her expertise is on fish histology and microbiology Ms. Maria Chiara Cascarano, Biologist with MSc (PhD candidate). Her expertise is on genomics and bacteriology
Aquatic Biologicals is focused on Aquaculture Health. It has 3 main axes of activities: (i) Advanced diagnostics with the use of modern high-end tools (-omics) and collection of pathogens (biobank), (ii) development and production of autogenous vaccines for aquaculture and (iii) phage therapy. Aquatic Biologicals offers expertise and services needed for the sustainable development of aquaculture aiming to the prevention of diseases, minimization of antibiotic use, promotion of alternative and personalized medicine. Currently, Aquatic Biologicals is looking for private investment to build GMP compliant facilities for the manufacturing of its products.
Aquaculture is the fastest-growing food industry; however, diseases are a major impediment for their growth. Introduction of new cultured fishes (diversification), increasing demand for food supply (intensification) and climate change are challenges that eventually lead to novel pathogens requiring innovative solutions. The pharmaceutical industry is very reluctant to invest in licensing new therapeutics and new vaccines since aquaculture is relatively small and rather fragmented. Aquatic Biologicals fills in the gap created by the lack of commercially available products. We develop and produce innovative, customizable, eco-friendly technologies such as autogenous vaccines and phage therapy to combat diseases in a sustainable manner.